Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

Hallmark’s first-ever reality competition series, “Finding Mr. Christmas,” returns for Season 2, premiering Monday, Oct. 27, at 8 p.m. ET. Cord-cutters can watch the series live on Philo (7-day free ...

Philo - Philo offers a free trial, live channels, and on-demand streaming of top shows — including “Tyler Perry’s Sistas,” “South Park,” and more. Fubo - Stream BET, ESPN, Hallmark Channel, FX, and ...

To topple access barriers to Vertex Pharmaceuticals’ potentially lifesaving, yet often out-of-reach cystic fibrosis therapy Trikafta, a buyers club has resurfaced with a plan to introduce a discounted ...

Vertex said Tuesday that David DeStefano is retiring as president and chief executive, effective Nov. 10. The company added that its board has named Christopher Young as its new president and CEO, ...

Vertex, Inc. (NASDAQ:VERX) announced on Tuesday that president and CEO David DeStefano will step down from his roles effective November 10, 2025. Following an extensive search assisted by an ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.

V2X (NYSE:VVX) announced the sale of 2 million shares of its common stock by Vertex Aerospace Holdco. The company is not selling any shares in this offering and will not receive any proceeds. The ...

Vertex Pharmaceuticals (VRTX) plunged after Q2 earnings and is now down 21% over the past year. The company has historically had a strong R&D pipeline and has consistently been a winner, but the ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators said they didn’t see a path forward for broad use of its pill in treating a ...